Description

Ibandronic Acid Injections 1 mg/ml. 3 ml. Vial №1

Ingredients

Each 3 ml vial contains 3 mg of Ibandronic Acid.

Dosage

The recommended dosage is 1 mg/ml administered as a slow intravenous injection over at least 15 seconds once every 3 months.

Indications

Ibandronic Acid Injections are indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Contraindications

Do not use Ibandronic Acid Injections if you have hypocalcemia or a hypersensitivity to bisphosphonates.

Directions

Administer Ibandronic Acid Injections under the supervision of a healthcare professional. Follow the recommended dosage and administration guidelines strictly.

Scientific Evidence

Ibandronic Acid has been extensively studied in clinical trials for its efficacy in treating osteoporosis. Research published in the Journal of Bone and Mineral Research has shown that Ibandronic Acid significantly reduces the risk of vertebral fractures in postmenopausal women.

Pharmacological Effects: Ibandronic Acid is a potent bisphosphonate that inhibits bone resorption by osteoclasts, leading to increased bone mineral density and reduced fracture risk.

Comparative Effectiveness: Studies have demonstrated that Ibandronic Acid is as effective as other bisphosphonates in preventing fractures and improving bone health in postmenopausal women.